Series B · Biotech
Kytopen Corp: Series B
Develops non-viral, continuous flow cellular engineering technologies for cell therapy manufacturing
Funding history
Series B · This roundUndisclosed
Loading rounds…
Develops non-viral, continuous flow cellular engineering technologies for cell therapy manufacturing